These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7251856)

  • 1. Characterization of the porphobilinogen deaminase deficiency in acute intermittent porphyria. Immunologic evidence for heterogeneity of the genetic defect.
    Anderson PM; Reddy RM; Anderson KE; Desnick RJ
    J Clin Invest; 1981 Jul; 68(1):1-12. PubMed ID: 7251856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute intermittent porphyria: characterization of a novel mutation in the structural gene for porphobilinogen deaminase. Demonstration of noncatalytic enzyme intermediates stabilized by bound substrate.
    Desnick RJ; Ostasiewicz LT; Tishler PA; Mustajoki P
    J Clin Invest; 1985 Aug; 76(2):865-74. PubMed ID: 3897290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA polymorphism of human porphobilinogen deaminase gene in acute intermittent porphyria.
    Llewellyn DH; Elder GH; Kalsheker NA; Marsh OW; Harrison PR; Grandchamp B; Picat C; Nordmann Y; Romeo PH; Goossens M
    Lancet; 1987 Sep; 2(8561):706-8. PubMed ID: 2888941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual porphyria in double heterozygotes with porphobilinogen deaminase and uroporphyrinogen decarboxylase deficiencies.
    Doss MO
    Clin Genet; 1989 Feb; 35(2):146-51. PubMed ID: 2721023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic heterogeneity in acute intermittent porphyria: characterisation and frequency of porphobilinogen deaminase mutations in Finland.
    Mustajoki P; Desnick RJ
    Br Med J (Clin Res Ed); 1985 Aug; 291(6494):505-9. PubMed ID: 3928029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthetase.
    Lamon JM; Frykholm BC; Tschudy DP
    J Med Genet; 1979 Apr; 16(2):134-9. PubMed ID: 458830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RFLP analysis of three different types of acute intermittent porphyria.
    Kauppinen R; Peltonen L; Palotie A; Mustajoki P
    Hum Genet; 1990 Jul; 85(2):160-4. PubMed ID: 1973403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies in porphyria. IV. Expression of the gene defect of acute intermittent porphyria in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait.
    Sassa S; Solish G; Levere RD; Kappas A
    J Exp Med; 1975 Sep; 142(3):722-31. PubMed ID: 1165472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular forms of porphobilinogen deaminase in acute intermittent porphyria. A study by Western immunoblotting.
    Nunn AV; Gardner LC; Cox TM
    Q J Med; 1987 Jul; 64(243):589-99. PubMed ID: 3671663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France.
    Nordmann Y; Puy H; Da Silva V; Simonin S; Robreau AM; Bonaiti C; Phung LN; Deybach JC
    J Intern Med; 1997 Sep; 242(3):213-7. PubMed ID: 9350165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in acute intermittent porphyria detected by ELISA measurement of porphobilinogen deaminase.
    Lannfelt L; Wetterberg L; Gellerfors P; Lilius L; Floderus Y; Thunell S
    J Clin Chem Clin Biochem; 1989 Nov; 27(11):857-62. PubMed ID: 2607315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.
    Herrick AL; McColl KE; Moore MR; Brodie MJ; Adamson AR; Goldberg A
    Br J Clin Pharmacol; 1989 Apr; 27(4):491-7. PubMed ID: 2497768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria.
    Puy H; Deybach JC; Lamoril J; Robreau AM; Da Silva V; Gouya L; Grandchamp B; Nordmann Y
    Am J Hum Genet; 1997 Jun; 60(6):1373-83. PubMed ID: 9199558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA polymorphisms within the porphobilinogen deaminase gene in two Swedish families with acute intermittent porphyria.
    Lee JS; Anvret M; Lindsten J; Lannfelt L; Gellerfors P; Wetterberg L; Floderus Y; Thunell S
    Hum Genet; 1988 Aug; 79(4):379-81. PubMed ID: 2900803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria.
    Kostrzewska E; Gregor A
    Ann Clin Res; 1986; 18(4):195-8. PubMed ID: 3789651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of mutations in exon 10 of the porphobilinogen deaminase gene in patients with a CRIM-positive subtype of acute intermittent porphyria.
    Gu XF; de Rooij F; Voortman G; Te Velde K; Nordmann Y; Grandchamp B
    Am J Hum Genet; 1992 Sep; 51(3):660-5. PubMed ID: 1496994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute intermittent porphyria caused by defective splicing of porphobilinogen deaminase RNA: a synonymous codon mutation at -22 bp from the 5' splice site causes skipping of exon 3.
    Llewellyn DH; Scobie GA; Urquhart AJ; Whatley SD; Roberts AG; Harrison PR; Elder GH
    J Med Genet; 1996 May; 33(5):437-8. PubMed ID: 8733062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two different point G to A mutations in exon 10 of the porphobilinogen deaminase gene are responsible for acute intermittent porphyria.
    Delfau MH; Picat C; de Rooij FW; Hamer K; Bogard M; Wilson JH; Deybach JC; Nordmann Y; Grandchamp B
    J Clin Invest; 1990 Nov; 86(5):1511-6. PubMed ID: 2243128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence risk estimation of acute intermittent porphyria based on analysis of porphobilinogen deaminase activity: a Bayesian approach.
    Bonaïti-Pellié C; Phung L; Nordmann Y
    Am J Med Genet; 1984 Dec; 19(4):755-62. PubMed ID: 6517099
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.